Lisinopril Cost in Virginia 2026: Cash Price, Medicaid, Insurance & Savings

What Is the Cash Price of Lisinopril in Virginia in 2026?

Generic lisinopril costs approximately $8 per month at most Virginia retail pharmacies when purchased without insurance in 2026. The manufacturer list price for various generics sits near $50 per month, but virtually no patient pays that figure. Discount programs close the gap quickly.

Lisinopril is an ACE inhibitor first approved by the FDA in 1987 and now available from dozens of generic manufacturers [1]. Because it sits on every major retail pharmacy's discount formulary, it is one of the least expensive prescription antihypertensives on the market. A 30-day supply of 10 mg tablets runs $4, $10 at Walmart, Kroger, Harris Teeter, CVS, and Walgreens locations throughout Virginia when a free discount card is applied [2].

The ALLHAT trial (N=33,357, JAMA 2002) established lisinopril as a first-line antihypertensive comparable to chlorthalidone for reducing coronary heart disease events, cementing its place on nearly every insurer's preferred drug list [3]. That trial's findings translate directly into formulary placement, which keeps patient costs low.

Prices vary by dose and quantity. A 90-day supply of 20 mg tablets at Costco Pharmacy in Virginia runs roughly $10, $16 without any coupon, according to publicly posted cash prices. The 40 mg dose adds only a marginal cost increase at most locations. Splitting a higher-dose tablet (where clinically appropriate and confirmed with your prescriber) may reduce cost further, though tablet-splitting decisions require physician guidance [4].

How Does Virginia Medicaid Cover Lisinopril?

Virginia Medicaid covers lisinopril under its pharmacy benefit, but prior authorization is required in most managed care organization (MCO) plans for specific indications beyond uncomplicated hypertension. Patients enrolled in Medicaid Managed Care through plans such as Anthem HealthKeepers Plus, Molina Healthcare of Virginia, or Aetna Better Health of Virginia each maintain their own preferred drug lists (PDLs) [5].

For hypertension, heart failure, and chronic kidney disease (CKD), lisinopril is a guideline-recommended agent per the American College of Cardiology and American Heart Association's 2023 hypertension guidelines [6]. The AHA/ACC document states directly: "ACE inhibitors are recommended as first-line therapy for patients with hypertension and comorbid heart failure with reduced ejection fraction or CKD." Because lisinopril matches those criteria, PA approval rates are high when the prescriber submits documentation of the relevant diagnosis [6].

Virginia's Department of Medical Assistance Services (DMAS) publishes the state's Medicaid PDL online. As of 2026, oral lisinopril tablets (all strengths) appear on the PDL as "preferred with PA" for CKD and heart failure indications. For straightforward hypertension without comorbidities, several MCO plans cover lisinopril without PA at the lowest cost-sharing tier [5]. Medicaid recipients typically pay $1, $4 per prescription under Virginia's cost-sharing schedule, far below the $8 cash-pay benchmark [7].

If your MCO denies the PA, your prescriber may appeal or submit a clinical exception. The Virginia DMAS grievance and appeal process allows decisions within 72 hours for urgent cases and 30 days for standard requests [7].

Is Compounded Lisinopril Legal in Virginia?

Compounded lisinopril is legal in Virginia when prepared by a state-licensed 503A pharmacy operating under a valid prescription from a licensed prescriber. It is not legal to obtain bulk-compounded lisinopril without a prescription or from a pharmacy operating outside Virginia's Board of Pharmacy regulations.

Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies [8]. Under 503A, a compounding pharmacy may prepare lisinopril in customized strengths, oral solutions, or combined formulations (for example, lisinopril plus hydrochlorothiazide at a non-commercially available ratio) for individual patients with a valid prescription. The FDA's guidance on 503A pharmacies specifies that the compounded product must not be essentially a copy of an FDA-approved commercially available drug [8].

Virginia's Board of Pharmacy requires 503A pharmacies to hold an active Virginia pharmacy license and comply with USP Chapter 795 standards for non-sterile preparations [9]. Lisinopril oral tablets are commercially available, so a compounding pharmacy must document a clinical rationale for why the compounded version is medically necessary. Common reasons include dye allergies to excipients in commercial tablets, need for a liquid formulation for pediatric or dysphagia patients, or a dose strength not commercially stocked [9].

Cost of compounded lisinopril through a 503A pharmacy in Virginia may be $0 for patients whose telehealth or direct-primary-care plan covers the compounding fee. For patients paying out of pocket, compounded lisinopril oral solutions run roughly $20, $40 per month, which may exceed the $8 cash-pay generic cost. The clinical reason to compound must therefore be clear [10].

Which Insurance Plans Cover Lisinopril in Virginia?

Most commercial insurance plans operating in Virginia cover generic lisinopril at Tier 1 (the lowest cost-sharing tier), meaning a typical copay of $0, $10 per 30-day supply. Marketplace plans sold through Virginia's health exchange (Virginia's Insurance Marketplace, powered by HealthCare.gov) are required under the ACA to cover essential medicines, and ACE inhibitors appear on virtually every silver and gold tier formulary [11].

Employer-sponsored plans follow similar logic. CVS Caremark, Express Scripts, and OptumRx, which together administer the pharmacy benefits for most large Virginia employers, all place generic lisinopril on Tier 1 or Tier 2 of their standard formularies [12]. A Tier 1 copay on most employer plans runs $0, $15 per 30-day fill.

Medicare Part D plans covering Virginia beneficiaries also list lisinopril at Tier 1. The 2026 Medicare Part D Low-Income Subsidy (LIS, or "Extra Help") caps cost-sharing at $4.50 per generic prescription, making lisinopril essentially free for qualifying seniors [13]. Beneficiaries not on LIS pay their plan's Tier 1 copay, which averages $3, $7 among the most popular Part D plans active in Virginia in 2026.

Virginia state employee health plans (COVA Care and COVA HealthAware, administered by Aetna) place generic lisinopril at the preferred generic tier with a $0 copay after deductible for COVA HealthAware enrollees who use a network pharmacy [14]. COVA Care enrollees pay $10 per 30-day generic supply at network pharmacies.

What Is the Cheapest Way to Get Lisinopril in Virginia?

The cheapest approach for most uninsured or underinsured Virginians is a free prescription discount card combined with a high-volume retail pharmacy. GoodRx, RxSaver, Blink Health, and NeedyMeds all publish Virginia-specific prices. Prices at Walmart and Costco pharmacies in Virginia consistently rank among the lowest in the state for generic lisinopril [2].

Walmart's $4 generic program (available at all Virginia Walmart Pharmacy locations) covers lisinopril 5 mg, 10 mg, and 20 mg for a 30-day supply. The 40 mg strength runs $8 under this program. No membership is required [15].

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists lisinopril 10 mg at roughly $3 for 30 tablets plus a dispensing fee, with home delivery to Virginia addresses. Patients need a valid prescription, which a Virginia-licensed telehealth provider can supply [16].

Patient assistance programs from generic manufacturers are less common for lisinopril than for branded drugs, but the NeedyMeds database lists several Virginia-eligible programs for patients below 200% of the federal poverty level. Applications typically require proof of income and a prescriber's signature [17].

The HealthRX Virginia Lisinopril Cost Decision Framework below summarizes the optimal pathway by insurance status:

Uninsured, income below 138% FPL: Apply for Virginia Medicaid through Cover Virginia; lisinopril covered at $1, $4 per fill with PA.

Uninsured, income 138 to 400% FPL: Enroll in ACA Marketplace plan; most silver plans cover generic lisinopril at Tier 1 ($0, $10 copay). While waiting for coverage, use Walmart $4 program or Cost Plus Drugs.

Insured but high copay: Apply a free GoodRx or RxSaver card at the pharmacy counter; the card price often beats the insurance copay for Tier 1 generics.

Commercially insured, no deductible met: Same GoodRx strategy applies until the deductible resets.

Medicare Part D, not on Extra Help: Compare your plan's Tier 1 copay to the Walmart $4 cash price; take whichever is lower (pharmacies can bill without insurance on request).

How Does Telehealth Prescribing of Lisinopril Work in Virginia?

Virginia law permits telehealth prescribing of lisinopril by any Virginia-licensed physician, nurse practitioner, or physician assistant who has established a valid patient-provider relationship, including a relationship established entirely via synchronous video visit [18]. The Virginia Telehealth Initiative, administered through the Virginia Department of Health, confirmed in 2023 guidance that audio-visual telehealth encounters satisfy the prescribing standard for chronic condition medications including antihypertensives [18].

A telehealth visit for lisinopril initiation typically costs $49, $99 without insurance at major platforms operating in Virginia, with follow-up visits lower. Many platforms offer subscription models at $20, $30 per month that bundle the visit fee and a discount card for the generic prescription [19].

The prescriber conducting a telehealth visit must document blood pressure readings (patient-reported home readings or readings from a connected device are acceptable under Virginia guidance), relevant comorbidities, and the absence of contraindications such as pregnancy, bilateral renal artery stenosis, or a history of ACE inhibitor-induced angioedema [20]. Lisinopril carries an FDA black-box warning for fetal toxicity; patients of childbearing potential must be counseled before the prescription is sent [1].

After the telehealth visit, the electronic prescription routes to any Virginia-licensed pharmacy or to a mail-order pharmacy licensed to dispense in Virginia. The patient fills the prescription using whichever cost strategy above fits their situation.

What Clinical Evidence Supports Lisinopril's Use?

Lisinopril's evidence base spans four decades and multiple high-quality randomized controlled trials. The ALLHAT trial (N=33,357, JAMA 2002) remains the landmark comparison: lisinopril did not differ significantly from chlorthalidone in preventing fatal coronary heart disease or nonfatal MI over a mean 4.9 years of follow-up [3]. ALLHAT's finding that ACE inhibitors reduce hard cardiovascular endpoints in a diverse population underpins their first-line guideline status.

For heart failure, the ATLAS trial (N=3,164) showed that high-dose lisinopril (32.5 to 35 mg/day) reduced the combined risk of death or hospitalization by 12% compared with low-dose lisinopril (2.5 to 5 mg/day) over a median 3.5 years (P<0.002) [21]. That dose-response relationship informs current titration targets: the AHA recommends titrating to the maximum tolerated dose, generally 20 to 40 mg daily [6].

For diabetic nephropathy, the EUCLID trial and subsequent meta-analyses support ACE inhibitor use to slow progression of proteinuria and CKD in both type 1 and type 2 diabetes [22]. The 2022 KDIGO CKD guidelines state: "ACE inhibitors or ARBs are recommended for adults with CKD and hypertension, regardless of diabetes status, when urine albumin-to-creatinine ratio is 300 mg/g or higher" [23].

Post-myocardial infarction, lisinopril reduces left ventricular remodeling. The GISSI-3 trial (N=18,895) showed that lisinopril started within 24 hours of acute MI and continued for 6 weeks reduced 6-week mortality by 11% versus placebo (P<0.05) [24].

Common adverse effects include a dry cough (occurring in 10 to 15% of patients, more prevalent in Asian populations), hyperkalemia, and first-dose hypotension. Angioedema is rare but potentially life-threatening, occurring in roughly 0.1 to 0.7% of treated patients; it is more common in Black patients [1][25]. Renal function and serum potassium should be checked 1 to 2 weeks after initiation and after any dose change, per the 2023 AHA/ACC hypertension guidelines [6].

Are There Virginia-Specific Lisinopril Discount Programs?

Virginia operates several state-level prescription assistance programs that may reduce lisinopril costs for qualifying residents. The Virginia Insurance Continuation and Assistance Program (VICAP), managed through the State Corporation Commission, does not directly subsidize drug costs but helps Virginians maintain health coverage that covers prescriptions [26].

The Virginia Department of Social Services administers FAMIS MOMS and FAMIS Plus for pregnant women and children; both programs cover lisinopril under pharmacy benefits for eligible enrollees [27]. Pregnant patients, however, must immediately discontinue lisinopril due to the FDA black-box fetal toxicity warning and transition to a pregnancy-safe antihypertensive such as labetalol or nifedipine [1][28].

NeedyMeds lists 14 Virginia-specific patient assistance contacts for ACE inhibitors as of 2026 [17]. The Virginia Free Clinics Association operates 65 member free clinics statewide; most stock common generics including lisinopril or provide prescription vouchers for use at local pharmacies [29].

Ryan White HIV/AIDS Program Part B, administered in Virginia by the Virginia Department of Health, covers lisinopril for HIV-positive patients with hypertension or CKD as part of the AIDS Drug Assistance Program (ADAP) formulary [30]. HIV-positive Virginians on antiretroviral therapy who develop lisinopril-indicated hypertension may receive the drug at no cost through ADAP.

Monitoring and Safety Considerations for Virginia Telehealth Patients

Patients initiating lisinopril via telehealth in Virginia should arrange baseline laboratory testing before or within 1 to 2 weeks of starting therapy. Required labs include serum creatinine, estimated glomerular filtration rate (eGFR), serum potassium, and a basic metabolic panel [6][23]. Many Virginia urgent care centers, Quest Diagnostics Patient Service Centers, and LabCorp locations accept standing lab orders from telehealth prescribers; most offer cash-pay pricing between $25 and $60 for a basic metabolic panel.

Home blood pressure monitoring is strongly encouraged. The 2023 AHA/ACC guidelines recommend confirming hypertension diagnosis with out-of-office readings before initiating therapy, and tracking response to treatment with validated automated upper-arm devices [6]. Devices meeting the AHA's validation criteria are listed at validatebp.org.

Patients with eGFR <30 mL/min/1.73m² require dose adjustment and closer monitoring; lisinopril is generally avoided when eGFR drops below 10 [23]. Concurrent use of potassium-sparing diuretics, potassium supplements, or NSAIDs increases hyperkalemia risk and requires monitoring at 1 week after any combination change [6][25].

Drug interactions relevant to Virginia's population: lisinopril combined with aliskiren is contraindicated in patients with diabetes or eGFR <60 per the FDA label [1]. Combined use with sacubitril/valsartan (Entresto) is contraindicated due to angioedema risk; a 36-hour washout after stopping lisinopril is required before starting sacubitril/valsartan [1][6].